The use of etanercept as a non-surgical treatment for temporomandibular joint psoriatric arthritis: A case report

Australian Dental Journal

Volumn 54, Issue 2, 2009, Pages 161-165

  Lamazza, L ^a   Guerra, F ^a   Pezza, M ^b   Messina, A M ^a   Galluccio, A ^b   Spink, M ^c   De Biase, Alberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Sacro Cuore di Gesù Hospital   (Italy)

^c BAYSTATE MEDICAL CENTER   (United States)

Author keywords

Etanercept; Immunomodulators; Psoriatic arthritis; TMJ

Indexed keywords

ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN G; NONSTEROID ANTIINFLAMMATORY AGENT; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; CASE REPORT; HUMAN; MALE; PSORIATIC ARTHRITIS; TEMPOROMANDIBULAR JOINT DISORDER; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; HUMANS; IMMUNOGLOBULIN G; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; TEMPOROMANDIBULAR JOINT DISORDERS; TREATMENT OUTCOME;

EID: 70350324630     PISSN: 00450421     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1834-7819.2009.01110.x     Document Type: Article

References (34)

1. Gladman DD, Farewell VT, Nadeau C. Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model. J Rheumatol 1995;22:675-679.
2. Mease PJ, Antoni CE. Psoriatic arthritis treatment: biological response modifiers. Ann Rheumatic Dis 2005;64:78-82.
3. Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PSA) - an analysis of 220 patients. Q J Med 1987;62:127-141.
4. Kelley W, Harris E, Ruddy S, Sledge C. Textbook in Rheumatology. Philadelphia: WB Saunders, 1981:1021-1031.
5. Kammer GM, Soter NA, Gibson DJ, Schur PH. Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients. Semin Arthritis Rheum 1979;9:75-97.
6. Laurent MR. Psoriatic arthritis. Clin Rheum Dis 1985;11:61-85.
7. Hellgren L. Association between rheumatoid arthritis and psoriasis in total populations. Acta Rheumatol Scand 1969;15:316-326.
8. Veale D, Yanni G, Rogers S, Barnes L, Bresnihan B, Fitzgerald O. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 1993;36:893-900.
9. Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM. Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 2003;111:821-831.
10. Resnick D, Niwayama G. Psoriatic arthritis. In: Resnick D, Niwayama G, eds. Diagnosis of bone and joint disorders. Philadelphia: WB Saunders, 1981:1103-1109.
11. Resnick D, Niwayama G. Psoriatic arthritis. In: Resnick D, Niwayama G, eds. Bone and joint imaging. Philadelphia: WB Saunders, 1989:320-328.
12. Balding J, Kane D, Livingstone W, et al. Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity. Arthritis Rheum 2003;48:1408-1413.
13. Baetz K, Klineberg I. Psoriatic arthritis of the temporomandibular joint. Case report. Aust Dent J 1986;31:335-339.
14. Anandarajah AP, Ritchlin CT. Pathogenesis of psoriatic arthritis. Curr Opin Rheumatol 2004;16:338-343.
15. Gladman DD, Brockbank J. Psoriatic arthritis. Expert Opin Investig Drugs 2000;9:1511-1522.
16. Jajic Z, El-Assadi G. The frequency of psoriatic arthritis in population of patients with psoriasis. Rheumatologia 2003;17:169-172. (Pubitemid 37351509)
17. Rasmussen OC, Bakke M. Psoriatic arthritis of the temporomandibular joint. Oral Surg Oral Med Oral Pathol 1982;53:351-357.
18. van Romunde LK, Valkenburg HA, Swart-Bruinsma W, Cats A, Hermans J. Psoriasis and arthritis. I. A population study. Rheumatol Int 1984;4:55-60.
19. Gisondi P, Girolomoni G. Biologic therapies in psoriasis: a new therapeutic approach. Autoimmun Rev 2007;6:515-519.
20. Winterfield LS, Menter A, Gordon K, Gottlieb A. Psoriasis treatment: current and emerging directed therapies. Ann Rheum Dis 2005;64:87-90.
21. Kopp S, Alstergren P, Ernestam S, Nordahl S, Morin P, Bratt J. Reduction of temporomandibular joint pain after treatment with a combination of methotrexate and infliximab is associated with changes in synovial fluid and plasma cytokines in rheumatoid arthritis. Cells Tissues Organs 2005;180:22-30.
22. Alstergren P, Larsson PT, Kopp S. Successful treatment with multiple intra-articular injections of infliximab in a patient with psoriatic arthritis. Scand J Rheumatol 2008;37:155-157.
23. Lundberg M, Ericson S. Changes in the temporomandibular joint in psoriasis arthropathica. Acta Derm Venereol 1967;47:354-358.
24. Blair GS. Psoriatic arthritis and the temporomandibular joint. J Dent 1976;4:123-128.
25. Koorbusch GF, Zeitler DL, Fotos PG, Doss JB. Psoriatic arthritis of the temporomandibular joints with ankylosis. Literature review and case reports. Oral Surg Oral Med Oral Pathol 1991;71:267-274.
26. Dervis E, Dervis E. The prevalence of temporomandibular disorders in patients with psoriasis with or without psoriatic arthritis. J Oral Rehabil 2005;32:786-793.
27. Franks AS. Temporomandibular joint arthrosis associated with psoriasis. Report of a case. Oral Surg Oral Med Oral Pathol 1965;19:301-303.
28. Franks AS. Temporomandibular joint in adult rheumatoid arthritis. A comparative evaluation of 100 cases. Ann Rheum Dis 1969;28:139-145.
29. Könönen M. Subjective symptoms from the stomatognathic system in patients with psoriatic arthritis. Acta Odontol Scand 1986;44:377-383.
30. Loebl DH, Kirby S, Stephenson R, Cook E, Mealing HG Jr, Bailey JP Jr. Psoriatic arthritis. JAMA 1979;242:2447-2451.
31. Wilson AW, Brown JS, Ord RA. Psoriatic arthropathy of the temporomandibular joint. Oral Surg Oral Med Oral Pathol 1990;70:555-558.
32. Chang J, Girgis L. Clinical use of anti-TNF-alpha biological agents-a guide for GPs. Aust Fam Physician 2007;36:1035-1038.
33. McCarty DJ, Bennett RM. Arthritis and allied conditions. 9th edn. Philadelphia: Lea & Febiger, 1979:642-655.
34. Miles DA, Kaugars GA. Psoriatic involvement of the temporomandibular joint. Literature review and report of two cases. Oral Surg Oral Med Oral Pathol 1991;71:770-774.